BioSpace News Archive

MediWound Ltd. today announced positive data from its Phase I/II study to evaluate the safety and efficacy of MW005 in the treatment of low-risk Basal Cell Carcinoma (BCC).

Connect Biopharma Holdings Limited today announced it presented four posters at the 25th World Congress of Dermatology being held in Singapore from July 3-8, 2023.

Voyager Therapeutics, Inc. today announced the appointment of Jacquelyn Fahey Sandell as Chief Legal Officer (CLO).

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced it has enrolled and dosed the first subject in the company’s Phase 2 study evaluating Ampligen ® as a potential therapeutic for people with post-COVID conditions (“AMP-518”).

NANOBIOTIX announced a global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, for the investigational, potential first-in-class radioenhancer NBTXR3.

Hemogenyx Pharmaceuticals plc announces that the Company has received a full review letter from the U.S. Food and Drug Administration regarding the Investigational New Drug application forthe Company’s product candidate Chimeric Antigen Receptor T-cells for the treatment of acute myeloid leukaemia to the effect that HEMO-CAR-T be put on clinical hold.

Skanska has signed a contract amendment with Oregon Health & Science University for its Hospital Expansion Project in Portland, Oregon, USA.

Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities will present a technical session at BIOPLUS-INTERPHEX KOREA 2023 for biotechs planning regional or global trials.

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, announced that the company plans to release its second quarter 2023 financial results after the close of the U.S. financial markets on August 1, 2023.

RaySearch Laboratories AB announces that Lausanne Univeristy Hospital, Switzerland, has treated their first patient using RayStation®* treatment planning system together with the oncology information system RayCare®* in combination with the Accuray CyberKnife® treatment delivery system.